Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for VASC
14.95
+0.02 (0.13%)
May 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 14.77 - 15.07
52 week 10.74 - 17.18
Open 14.78
Vol / Avg. 53,417.00/56,940.00
Mkt cap 246.80M
P/E 24.45
Div/yield     -
EPS 0.61
Shares 16.51M
Beta 0.15
Inst. own 50%
Aug 14, 2013
Vascular Solutions, Inc. at Canaccord Genuity Growth Conference Add to calendar
Jul 22, 2013
Q2 2013 Vascular Solutions, Inc. Earnings Release Add to calendar
Jun 3, 2013
Vascular Solutions, Inc. at Jefferies Global Healthcare Conference Add to calendar
May 30, 2013
Vascular Solutions, Inc. at Benchmark Company, LLC One-on-One Investor Conference - 2:10PM EDT - Add to calendar
May 29, 2013
Vascular Solutions, Inc. at Deutsche Bank dbAccess Health Care Conference Add to calendar
May 15, 2013
Vascular Solutions, Inc. at Bank of America Merrill Lynch Health Care Conference
Apr 23, 2013
Q1 2013 Vascular Solutions, Inc. Earnings Conference Call - Webcast
Apr 22, 2013
Q1 2013 Vascular Solutions, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 8.15% 10.07%
Operating margin 11.14% 16.17%
EBITD margin - 19.78%
Return on average assets 9.48% 12.05%
Return on average equity 10.92% 13.80%
Employees 377 -
Carbon Disclosure Rating - -

Address

6464 SYCAMORE COURT
MINNEAPOLIS, MN 55369
United States - Map
+1-763-6564300 (Phone)
+1-763-6564250 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Vascular Solutions, Inc. (Vascular) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists. Vascular offers product and service in three categories: catheter products, hemostat products and vein products and services. Catheter products consist of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions. Hemostat (blood clotting) products consist of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable. Vein products consist of the Vari-Lase endovenous laser. In December 2011, it acquired 5-year rights to sell reprocessing services for the ClosureFast catheter in the United States from Northeast Scientific, Inc. In June 2012, the Company acquired the radial artery access wrist positioning splint product assets of Accumed Systems, Inc.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Howard Root Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 40
Bio & Compensation  - Reuters
William Rutstein Senior Vice President - Worldwide Sales
Age: 60
Bio & Compensation  - Reuters
Charmaine Sutton Senior Vice President - Operations
Age: 53
Bio & Compensation  - Reuters
Susan Christian Vice President - Sales Operations
Age: 44
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 38
Bio & Compensation  - Reuters
Brett Demchuk Vice President - Product Quality
Age: 49
Bio & Compensation  - Reuters
Jonathan M. Hammond Vice President - Manufacturing Engineering
Age: 45
Bio & Compensation  - Reuters
Phillip Nalbone Vice President - Corporate Development
Age: 51
Bio & Compensation  - Reuters